Answers are grounded in this paper and cite their sources.
Over the years there has been great interest in treatment of patients with moderate to severe asthma presenting to the emergency department. To make a dent in these exacerbations, clinicians have modified label recommendations for short-acting bronchodilators with innovative delivery techniques,
No takes yet. Share an insight, caveat, or question.
Fink et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: